Detalhe da pesquisa
1.
Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
Gut
; 72(4): 624-637, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002248
2.
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency.
Gut
; 71(3): 467-478, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785559
3.
Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Gut
; 69(1): 18-31, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171626